Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The use of 18F-fluorodeoxyglucose positron emission tomography for the diagnosis and management of invasive mould infections.

Literature DB >> 18297544

The use of 18F-fluorodeoxyglucose positron emission tomography for the diagnosis and management of invasive mould infections.

Georgios Chamilos¹, Homer A Macapinlac, Dimitrios P Kontoyiannis.

Abstract

There is limited information on the utility of 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) for the diagnosis and management of invasive mould infections (IMIs). We retrospectively evaluated patients with IMIs who underwent FDG-PET in our institution (n = 13; December 1999 to April 2004), and reviewed the available literature (n = 9). In 16 non-neutropenic patients with available FDG-PET imaging studies (11 from our institution), FDG-PET revealed an occult IMI site (n = 3; 2 unidentified CNS involvement) and was helpful in guiding the duration of treatment (n = 8). Prospective evaluation of the role of FDG-PET in the work-up and management of IMIs is needed.

Entities: Chemical Disease Species

Mesh：

Substances：
Fluorodeoxyglucose F18

Year: 2008 PMID： 18297544 DOI： 10.1080/13693780701639546

Source DB: PubMed Journal: Med Mycol ISSN： 1369-3786 Impact factor: 4.076

Keyword Cloud
Cited

20 in total

Review 1. Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer consensus criteria.

Authors: Brahm H Segal; Raoul Herbrecht; David A Stevens; Luis Ostrosky-Zeichner; Jack Sobel; Claudio Viscoli; Thomas J Walsh; Johan Maertens; Thomas F Patterson; John R Perfect; Bertrand Dupont; John R Wingard; Thierry Calandra; Carol A Kauffman; John R Graybill; Lindsey R Baden; Peter G Pappas; John E Bennett; Dimitrios P Kontoyiannis; Catherine Cordonnier; Maria Anna Viviani; Jacques Bille; Nikolaos G Almyroudis; L Joseph Wheat; Wolfgang Graninger; Eric J Bow; Steven M Holland; Bart-Jan Kullberg; William E Dismukes; Ben E De Pauw
Journal: Clin Infect Dis Date: 2008-09-01 Impact factor: 9.079

2. FDG PET/CT imaging in detecting and guiding management of invasive fungal infections: a retrospective comparison to conventional CT imaging.

Authors: A P Douglas; K A Thursky; L J Worth; E Drummond; A Hogg; R J Hicks; M A Slavin
Journal: Eur J Nucl Med Mol Imaging Date: 2018-06-07 Impact factor: 9.236

Review 3. Diagnosis and treatment of invasive fungal infections in the cancer patient: recent progress and ongoing questions.

Authors: Dimitrios P Kontoyiannis; Thomas F Patterson
Journal: Clin Infect Dis Date: 2014-11-15 Impact factor: 9.079

4. Widespread skin nodules as a manifestation of breakthrough invasive aspergillosis in a bone marrow transplant patient.

Authors: Manuel Abecasis; Isabelina Ferreira; Gilda Teixeira; Nuno Miranda
Journal: Clin Drug Investig Date: 2013-02 Impact factor: 2.859

5. How I transplant a patient with a history of invasive fungal disease.

Authors: Pedro Puerta-Alcalde; Richard Champlin; Dimitrios P Kontoyiannis
Journal: Blood Date: 2020-08-26 Impact factor: 22.113

Review 6. How I treat mucormycosis.

Authors: Dimitrios P Kontoyiannis; Russell E Lewis
Journal: Blood Date: 2011-05-26 Impact factor: 22.113

10. How Long Do We Need to Treat an Invasive Mold Disease in Hematology Patients? Factors Influencing Duration of Therapy and Future Questions.

Authors: Ana Fernández-Cruz; Russell E Lewis; Dimitrios P Kontoyiannis
Journal: Clin Infect Dis Date: 2020-07-27 Impact factor: 9.079